Newborn dried blood spots for serological surveys of COVID-19

This article has 1 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

There is an urgent need for inexpensive, population-wide surveillance testing for COVID-19. We tested newborn dried blood spots (DBS) anti-SARS-COV-2 antibodies for all infants born at Yale from March-May 2020, and found that newborn DBS serologies reflect maternal and population-wide infection rates during the study period. This suggests a role for DBS in COVID-19 surveillance in areas where viral testing is limited.

Related articles

Related articles are currently not available for this article.